A significant race/ethnicity-by-APOEε4 interaction was previously reported for CSF tau levels [65]; however, whether plasma apoE contributes directly or indirectly to AD risk in ε4 negative B/AA by influencing the levels of CSF tau levels, indicative of brain tau pathology, needs further research. Here, MAPT is linked to Alzheimer disease.